Morphine
Formulation
The table below describes the formulation of morphine sulfate and the controls pregabalin, ketoprofen, and gabapentin for the experiments shown on this page. For MIA studies, morphine showed efficacy in all endpoints tested and is used as the positive control when testing other compounds in this model; therefore, no additional positive control is used in the MIA morphine dose response studies.
Experiment(s) | Compound | Dose(s) mg/kg | Correction factor | Dose volume mL/kg | Route | Vehicle | Suspension / Solution |
---|---|---|---|---|---|---|---|
Pharmacokinetics | Morphine | 6 | 1.33 | 1 | SC | Saline | Solution |
Irwin, Rotarod | Morphine | 1, 3, 6, 10 | 1.33 | 1 | SC | Saline | Solution |
Plantar incision | Morphine | 1, 3, 6 | 1.33 | 1 | SC | Saline | Solution |
L5/L6 SNL, MIA | Morphine | 0.3, 1, 3, 6 | 1.33 | 1 | SC | Saline | Solution |
Plantar incision | Pregabalin | 30 | 1.00 | 1 | PO | Saline | Solution |
Plantar incision | Ketoprofen | 6 | 1.00 | 1 | PO | Saline | Suspension |
L5/L6 SNL | Gabapentin | 60 | 1.00 | 1 | PO | Saline | Solution |
L5/L6 SNL = L5/L6 spinal nerve ligation; MIA = monosodium iodoacetate; PO = per os; SC = subcutaneous
Results
Expand and Collapse accordion content
This work was conducted by PsychoGenics Inc. (Paramus, NJ) in collaboration with PSPP, NINDS, NIH under contract # 75N95019D00026. Prescribing information for clinically used controls can be found at labels.fda.gov.